Physician profile
Joseph G Cabrera
NPI 1861475972
$1,542.10
in general payments reported to CMS, 2019-2025
22 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.51 · 2020: $226 · 2021: $278 · 2022: $279 · 2023: $169 · 2024: $187 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $223.24 | 2023-2025 | |
| Stryker Corporation | $188.50 | 2020-2022 | |
| Smith+Nephew, INC. | $161.61 | 2022-2025 | Grafix Pl, Stravix Pl, Grafix |
| Journey Medical Corporation | $135.97 | 2019-2024 | |
| Organogenesis INC. | $128.71 | 2019-2022 | |
| Bioventus LLC | $94.14 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Tactile Systems Technology INC | $72.03 | 2025 | Nimbl, Flexitouch Plus |
| Horizon Therapeutics Plc | $71.11 | 2021 | |
| Sebela Pharmaceuticals INC. | $69.91 | 2021-2023 | Naftin |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $60.23 | 2020-2022 | |
| Convatec INC. | $58.25 | 2022-2023 | |
| Paratek Pharmaceuticals, INC. | $56.81 | 2024-2025 | Nuzyra |
| Alfasigma USA, INC. | $53.83 | 2020-2021 | |
| Gotham Surgical Solutions & Devices, INC. | $41.50 | 2020 | |
| Zimmer Biomet Holdings, INC. | $21.99 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $19.71 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Amgen INC. | $18.15 | 2025 | Krystexxa |
| Novum Pharma, LLC | $15.71 | 2019 | |
| Pfizer INC. | $14.99 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.17 | 2023 | Seglentis |
| Integra Lifesciences Corporation | $12.40 | 2020 | |
| Advanced Oxygen Therapy INC. | $10.14 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cabrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.